Design, synthesis, cytotoxic, and anti-inflammatory activities of some novel analogues of aloe-emodin isolated from the rhizomes of Rheum emodi. Issue 9 (3rd May 2023)

• Record Type: Journal Article
• Authors: Dileep Kumar, G.; Siva, Bandi; Ashwini, K.; Vinod Kumar, J.; Ramalingam, V.; Sai Balaji, A.; Suresh Babu, K.
• Is Part Of: Natural product research. Volume 37:Issue 9(2023)
• Page Start: 1511
• Page End: 1517
• Publication Date: 2023-05-03
• Subjects: Rheum emodi -- aloe-emodin -- tri-component reaction -- furan derivatives -- anticancer -- anti-inflammatory activity; Natural products -- Periodicals; Natural products -- Research -- Periodicals; Biological Factors -- Periodicals; Biological Products -- Periodicals; 547
• DOI: 10.1080/14786419.2021.2024531
• Languages: English
• ISSNs: 1478-6419

Abstract

Abstract: In connection with our continuous efforts in the synthesis of derivatives from major compounds isolated from traditional medicinal plants, in the present study we have attempted to synthesize the furan-conjugated aloe-emodin derivatives (5a–j ) using a three-component reaction. The synthesized derivatives were assessed for anticancer activity against five different cancer cell lines using the in vitro MTT assay and the results showed that most of the derivatives are potent against cancer cells comparing with the control. Compounds 5a and 5e showed excellent activity against all the cancer cells with less than 12.5 µM and arrested the cell cycle at the G0/G1 phase in both CAL27 and SCC9 cells. Compound 5e induces the early apoptosis in CAL27 cells and compounds 5a and 5e induce early and late apoptosis, respectively, in SCC9 cells. Moreover, compounds 5b, 5c, 5i, and 5j showed excellent anti-inflammatory activity in LPS-stimulated RAW 264.7 cells by inhibiting IL-6 production. The molecular docking studies revealed that compound 5e has strong interaction with the CLK kinase and protein kinase II through hydrogen binding Asp325 and Lys290. Graphical Abstract: UF0001